A research team at the Institute for Basic Science (IBS) research team has identified how autism spectrum disorders impair social interaction and provided clues for better understanding and treating declined social communication caused by autism.In a previous study, the research team found that Shan
Chong Kun Dang said Thursday that its U.S. partner, Cara Therapeutics, has received approval from the Food and Drug Administration for uremic pruritus treatment, CR-845.Chong Kun Dang participated in developing CR-845, branded as Korsuva, after gaining exclusive rights for domestic development and s
Three biopharmaceutical companies developing Covid-19 vaccines or treatments received 70 percent of the government subsidies totaling more than 50 billion won ($42.2 million) in the first half of this year, according to their semiannual reports.SK Bioscience received 16.5 billion won from the govern
The government confirmed Thursday that the Moderna vaccine supplied in Korea does not fall under the same lot numbers of contaminated vaccines as those found in Japan.Japan’s Ministry of Health, Labor and Welfare said recently it has received many reports that some of Moderna’s vaccine doses contain
About domestic 5,000 patients with neurofibromatosis type 1 (NF1) can now benefit from a new therapeutic option for treating the rare genetic disorder with the recent approval of AstraZeneca's Koselugo (ingredient: selumetinib), an expert said.Korean patients with NF1, which lacked a cure, had to re
Botulinum toxin (BTX) maker Hugel said Wednesday that a consortium led by GS Group acquired the majority of the company's shares from Bain Capital's Leguh Issuer Designated Activity Company for 1.7 trillion won ($1.46 billion).Leguh Issuer Designated Activity Company, a U.S. investment firm, agreed
Korea Pharma said Wednesday that it has signed a deal with a U.K. pharmaceutical company, Shield Therapeutics, to exclusively supply the latter's oral iron deficiency anemia therapy Accrufer (ingredient: ferric maltol) in Korea.Accrufer received approval from the U.S. Food and Drug Administration an
Sanofi-Aventis Korea has updated the newly confirmed long-term safety data of Dupixent (ingredient: dupilumab) in treating adult patients with atopic dermatitis in Korea.The recent update was based on the confirmed safety profile up to three years of an open-label extension study conducted on 2,677
The government's policy on the biopharmaceutical industry will play a pivotal role in occupying the global bio market amid its rapid growth fueled by the Covid-19 pandemic, a state-funded institute said.The Korea Health Industry Development Institute (KHIDI) published a report on the “next normal” o
Samsung Biologics has recently won the cell line patent invalidation trial filed in China against the Swiss multinational biotech company, Lonza, it was learned.In January, the company filed a trial for invalidation of cell line-related patents with China's National Intellectual Property Administrat
The global regenerative medicine industry is growing rapidly, and the Asia-Pacific region is a major center of growth for the sector driven primarily by the recently added new Korean and Taiwanese clinical trials, a report said.There are 1,320 industry-sponsored regenerative medicine and advanced th
Samsung Bioepis has won a marketing permit for its macular degeneration treatment Byooviz, a biosimilar of Lucentis (ingredient: ranibizumab), from the European Commission.The company had waited for two months since the Committee for Medicinal Products for Human Use (CHMP) under European Medicines A
Pharmaceutical companies expanded their employment despite the prolonging Covid-19 pandemic in the first half of this year, data showed.Notably, the number of employees at companies providing contracted manufacturing service for Covid-19 vaccines, such as Samsung Biologics and SK Bioscience, increas
The National Institute of Food and Drug Safety Evaluation (NIFDS) said it would hold a conference on regulatory trends, vaccine development, and innovative drugs concerning Covid-19, along with the Drug Information Association from Sept. 2-3.Officials from the U.S. Food and Drug Administration (FDA)
The Korea Health Industry Development Institute (KHIDI) said Thursday that it has set up a branch office at the Cambridge Innovation Center (CIC) in Boston, Mass.KHIDI USA Office will operate the support center to cooperate with the U.S. Food and Drug Administration, hosting online briefings for dom
Large pharmaceutical companies increased their investment into research and development in the first half of 2021 despite an uncertain profitability outlook due to the prolonging Covid-19 pandemic.According to semi-annual reports submitted to the Financial Supervisory Service, seven out of the top 1
The significance of vaccine sovereignty is becoming increasingly important in the protracted fight against the Covid-19 pandemic due to the disruption of stable vaccine supplies and emerging variants, a report on vaccine trends said Thursday. Homegrown vaccine development and securing sufficient sup
The Ministry of Food and Drug Safety said it has found 2-chloroethanol (2-CE) in some packets and raw ingredients of two Korean instant noodle brands exported to Europe, which were insufficient to cause any harm.The ministry added that ethylene oxide (EO), a carcinogen, was not detected in the two i
The negotiations on retrieving the reimbursement of pharmaceutical pricing for choline alfoscerate drugs to help treat dementia between the state health insurance agency and pharmaceutical companies have been concluded except for some drugmakers.After lengthy bargaining, the National Health Insuranc
Korean officials failed to receive a definite answer on the supply amount and timing of Moderna vaccines in a recent U.S. meeting, repeating their request to supply vaccines manufactured by Samsung Biologics to Korea first.The government has continued to send such requests to Moderna since June to l